11.57
-0.93
(-7.44%)
At close: April 10 at 4:00:02 PM EDT
11.53
-0.04
(-0.35%)
After hours: April 10 at 6:38:12 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-109,028
-109,028
-91,948
-52,635
-33,507
Investing Cash Flow
-184,656
-184,656
102,886
-70,577
-242,227
Financing Cash Flow
249,253
249,253
53,166
129,639
186,384
End Cash Position
41,666
41,666
86,097
21,993
15,566
Capital Expenditure
-1,312
-1,312
-5,745
-5,546
-668
Issuance of Capital Stock
239,147
239,147
52,618
129,165
186,148
Free Cash Flow
-110,340
-110,340
-97,693
-58,181
-34,175
12/31/2021 - 3/26/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CYTK Cytokinetics, Incorporated
37.85
+1.42%
JANX Janux Therapeutics, Inc.
26.87
+0.15%
LXEO Lexeo Therapeutics, Inc.
2.1700
-8.05%
MLTX MoonLake Immunotherapeutics
33.97
-5.59%
PCVX Vaxcyte, Inc.
28.04
-8.96%
DYN Dyne Therapeutics, Inc.
6.98
-7.55%
MLYS Mineralys Therapeutics, Inc.
12.19
-4.99%
APGE Apogee Therapeutics, Inc.
29.94
-5.85%
VERA Vera Therapeutics, Inc.
21.81
-0.95%
RVMD Revolution Medicines, Inc.
33.67
-4.13%